The Filings Report

Synopsys Inc

SNPSNasdaqCIK 883241Technology / Softwarefiscal year ends October69 quarters since 2009

Revenue, Q3 FY2026
$2.5B
+42.4% on Q3 FY2025
Net income
$546M
+125.1% on Q3 FY2025
Free cash flow
$746M
+18.0% on Q3 FY2025
Diluted EPS
$2.84
+89.3% on Q3 FY2025
Revenue, TTM
$9.4B
trailing four quarters
Net margin, TTM
11.4%
net income $1.1B
Free cash flow, TTM
$2.7B
$2.9B less $191M capex
Cash and equivalents
$3.6B
long-term debt $9.0B, Jul 31, 2026
Shares, 12-month change
+3.2%
192M shares, Jul 31, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$89.6B
at the close, buybacks

Latest quarter Q3 FY2026, filed August 26, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended July 31, 2026, Synopsys Inc reported revenue of $2.5B, +42.4% on Q3 FY2025, and net income of $546M (+125.1%). Net income this quarter is driven by non-operating items: $460M of other income against $357M of operating income, so it reflects gains or losses outside the operations. Operating margin was 14.4%. Free cash flow, operating cash flow less capital expenditures, was $746M ($813M less $67M). Diluted earnings per share were $2.84.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of August 26, 2026.

Revenue and net incomeRevenueNet income
$0$1B$2B$3BQ4'22, Revenue: $818MQ4'22, Net income: $154MQ4'22Q1'23, Net income: $272MQ1'23Q2'23, Net income: $273MQ2'23Q3'23, Net income: $336MQ3'23Q4'23, Net income: $349MQ4'23Q1'24, Revenue: $1.5BQ1'24, Net income: $449MQ1'24Q2'24, Revenue: $1.5BQ2'24, Net income: $292MQ2'24Q3'24, Revenue: $1.5BQ3'24, Net income: $408MQ3'24Q4'24, Revenue: $1.6BQ4'24, Net income: $1.1BQ4'24Q1'25, Revenue: $1.5BQ1'25, Net income: $296MQ1'25Q2'25, Revenue: $1.6BQ2'25, Net income: $345MQ2'25Q3'25, Revenue: $1.7BQ3'25, Net income: $243MQ3'25Q4'25, Revenue: $2.3BQ4'25, Net income: $449MQ4'25Q1'26, Revenue: $2.4BQ1'26, Net income: $65MQ1'26Q2'26, Revenue: $2.3BQ2'26, Net income: $17MQ2'26Q3'26, Revenue: $2.5BQ3'26, Net income: $546MQ3'26$0$1B$2B$3BQ4'22, Revenue: $818MQ4'22, Net income: $154MQ1'23, Net income: $272MQ1'23Q2'23, Net income: $273MQ3'23, Net income: $336MQ3'23Q4'23, Net income: $349MQ1'24, Revenue: $1.5BQ1'24, Net income: $449MQ1'24Q2'24, Revenue: $1.5BQ2'24, Net income: $292MQ3'24, Revenue: $1.5BQ3'24, Net income: $408MQ3'24Q4'24, Revenue: $1.6BQ4'24, Net income: $1.1BQ1'25, Revenue: $1.5BQ1'25, Net income: $296MQ1'25Q2'25, Revenue: $1.6BQ2'25, Net income: $345MQ3'25, Revenue: $1.7BQ3'25, Net income: $243MQ3'25Q4'25, Revenue: $2.3BQ4'25, Net income: $449MQ1'26, Revenue: $2.4BQ1'26, Net income: $65MQ1'26Q2'26, Revenue: $2.3BQ2'26, Net income: $17MQ3'26, Revenue: $2.5BQ3'26, Net income: $546MQ3'26

Net income losses drawn in red.

Free cash flow
−$250M$0$250M$500M$750M$1.0BQ4'22, Free cash flow: $360MQ4'22Q1'23, Free cash flow: $71MQ1'23Q2'23, Free cash flow: $655MQ2'23Q3'23, Free cash flow: $514MQ3'23Q4'23, Free cash flow: $273MQ4'23Q1'24, Free cash flow: −$128MQ1'24Q2'24, Free cash flow: $438MQ2'24Q3'24, Free cash flow: $415MQ3'24Q4'24, Free cash flow: $542MQ4'24Q1'25, Free cash flow: −$108MQ1'25Q2'25, Free cash flow: $220MQ2'25Q3'25, Free cash flow: $632MQ3'25Q4'25, Free cash flow: $605MQ4'25Q1'26, Free cash flow: $822MQ1'26Q2'26, Free cash flow: $575MQ2'26Q3'26, Free cash flow: $746MQ3'26−$250M$0$250M$500M$750M$1.0BQ4'22, Free cash flow: $360MQ1'23, Free cash flow: $71MQ1'23Q2'23, Free cash flow: $655MQ3'23, Free cash flow: $514MQ3'23Q4'23, Free cash flow: $273MQ1'24, Free cash flow: −$128MQ1'24Q2'24, Free cash flow: $438MQ3'24, Free cash flow: $415MQ3'24Q4'24, Free cash flow: $542MQ1'25, Free cash flow: −$108MQ1'25Q2'25, Free cash flow: $220MQ3'25, Free cash flow: $632MQ3'25Q4'25, Free cash flow: $605MQ1'26, Free cash flow: $822MQ1'26Q2'26, Free cash flow: $575MQ3'26, Free cash flow: $746MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $1.4BQ4'22, Long-term debt: $21MQ4'22Q1'23, Cash and equivalents: $1.2BQ1'23, Long-term debt: $21MQ1'23Q2'23, Cash and equivalents: $1.5BQ2'23, Long-term debt: $20MQ2'23Q3'23, Cash and equivalents: $1.7BQ3'23, Long-term debt: $18MQ3'23Q4'23, Cash and equivalents: $1.4BQ4'23, Long-term debt: $18MQ4'23Q1'24, Cash and equivalents: $1.1BQ1'24, Long-term debt: $17MQ1'24Q2'24, Cash and equivalents: $1.5BQ2'24, Long-term debt: $17MQ2'24Q3'24, Cash and equivalents: $1.8BQ3'24, Long-term debt: $16MQ3'24Q4'24, Cash and equivalents: $3.9BQ4'24, Long-term debt: $16MQ4'24Q1'25, Cash and equivalents: $3.7BQ1'25, Long-term debt: $14MQ1'25Q2'25, Cash and equivalents: $14.1BQ2'25, Long-term debt: $10.0BQ2'25Q3'25, Cash and equivalents: $2.5BQ3'25, Long-term debt: $14.3BQ3'25Q4'25, Cash and equivalents: $2.9BQ4'25, Long-term debt: $13.5BQ4'25Q1'26, Cash and equivalents: $2.1BQ1'26, Long-term debt: $10.0BQ1'26Q2'26, Cash and equivalents: $2.4BQ2'26, Long-term debt: $10.0BQ2'26Q3'26, Cash and equivalents: $3.6BQ3'26, Long-term debt: $9.0BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $1.4BQ4'22, Long-term debt: $21MQ1'23, Cash and equivalents: $1.2BQ1'23, Long-term debt: $21MQ1'23Q2'23, Cash and equivalents: $1.5BQ2'23, Long-term debt: $20MQ3'23, Cash and equivalents: $1.7BQ3'23, Long-term debt: $18MQ3'23Q4'23, Cash and equivalents: $1.4BQ4'23, Long-term debt: $18MQ1'24, Cash and equivalents: $1.1BQ1'24, Long-term debt: $17MQ1'24Q2'24, Cash and equivalents: $1.5BQ2'24, Long-term debt: $17MQ3'24, Cash and equivalents: $1.8BQ3'24, Long-term debt: $16MQ3'24Q4'24, Cash and equivalents: $3.9BQ4'24, Long-term debt: $16MQ1'25, Cash and equivalents: $3.7BQ1'25, Long-term debt: $14MQ1'25Q2'25, Cash and equivalents: $14.1BQ2'25, Long-term debt: $10.0BQ3'25, Cash and equivalents: $2.5BQ3'25, Long-term debt: $14.3BQ3'25Q4'25, Cash and equivalents: $2.9BQ4'25, Long-term debt: $13.5BQ1'26, Cash and equivalents: $2.1BQ1'26, Long-term debt: $10.0BQ1'26Q2'26, Cash and equivalents: $2.4BQ2'26, Long-term debt: $10.0BQ3'26, Cash and equivalents: $3.6BQ3'26, Long-term debt: $9.0BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed August 26, 2026.

Synopsys Inc income statement, quarterly
Millions of dollarsQ3 FY2026ended Jul 31, 2026filed Aug 26, 2026Q2 FY2026ended Apr 30, 2026filed May 27, 2026Q1 FY2026ended Jan 31, 2026filed Feb 25, 2026Q4 FY2025ended Oct 31, 2025filed Dec 22, 2025Q3 FY2025ended Jul 31, 2025filed Sep 9, 2025Q2 FY2025ended Apr 30, 2025filed May 28, 2025Q1 FY2025ended Jan 31, 2025filed Feb 26, 2025Q4 FY2024ended Oct 31, 2024filed Dec 19, 2024YoYQ3 FY2026vs Q3 FY2025
Revenue2,4772,2762,4092,2551,7401,6041,4551,636+42.4%
Cost of revenue679630637655381318270375+78.5%
Gross profit1,7971,6461,7711,6001,3591,2861,1851,261+32.2%
Research and development720700715747625554553555+15.1%
Selling, general and administrative177172183186281136167172−36.9%
Operating income357120203121165376252311+116.3%
Other income (expense)46032395901711145028+169.5%
Pretax income6841979517189396291323+261.3%
Income tax13821468(53)47(6)62+360.9%
Net income54617654492433452961,114+125.1%
Diluted EPS ($)2.840.090.34—1.502.211.89—+89.3%
Diluted shares (millions)192192191—162156156——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed August 26, 2026.

Synopsys Inc balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Jul 31, 2026filed Aug 26, 2026Q2 FY2026ended Apr 30, 2026filed May 27, 2026Q1 FY2026ended Jan 31, 2026filed Feb 25, 2026Q4 FY2025ended Oct 31, 2025filed Dec 22, 2025Q3 FY2025ended Jul 31, 2025filed Sep 9, 2025Q2 FY2025ended Apr 30, 2025filed May 28, 2025Q1 FY2025ended Jan 31, 2025filed Feb 26, 2025Q4 FY2024ended Oct 31, 2024filed Dec 19, 2024YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents3,6062,4122,1302,8882,52614,1193,6543,897+42.7%
Short-term investments172747367145155154−97.9%
Total current assets6,6445,4375,3746,0125,59616,8796,3246,470+18.7%
Total assets47,72646,88947,23848,22448,23023,75713,04113,074−1.0%
Total current liabilities4,9703,7913,9433,7223,4442,4062,3592,650+44.3%
Long-term debt9,01710,01410,02213,46214,31810,0281416−37.0%
Total liabilities16,57516,41216,69019,89720,61613,8413,7364,050−19.6%
Stockholders’ equity31,15330,47830,54928,32827,6159,9169,3058,991+12.8%
Shares outstanding (millions)192191192191186155155155—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed August 26, 2026.

Synopsys Inc cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Jul 31, 2026filed Aug 26, 2026Q2 FY2026ended Apr 30, 2026filed May 27, 2026Q1 FY2026ended Jan 31, 2026filed Feb 25, 2026Q4 FY2025ended Oct 31, 2025filed Dec 22, 2025Q3 FY2025ended Jul 31, 2025filed Sep 9, 2025Q2 FY2025ended Apr 30, 2025filed May 28, 2025Q1 FY2025ended Jan 31, 2025filed Feb 26, 2025Q4 FY2024ended Oct 31, 2024filed Dec 19, 2024YoYQ3 FY2026vs Q3 FY2025
Operating cash flow813629857640671275(67)563+21.1%
Capital expenditures6754353539564121+72.4%
Free cash flow (CFO − capex)746575822605632220(108)542+18.0%
Depreciation and amortization4554564514491144948115+297.4%
Share repurchases38——00——0—
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed December 22, 2025.

Income statement

Synopsys Inc income statement, annual
Millions of dollarsFY2025ended Oct 31, 2025filed Dec 22, 2025FY2024ended Oct 31, 2024filed Dec 19, 2024FY2023ended Oct 31, 2023filed Dec 12, 2023FY2022ended Oct 31, 2022filed Dec 12, 2022FY2021ended Oct 31, 2021filed Dec 13, 2021FY2020ended Oct 31, 2020filed Dec 15, 2020FY2019ended Oct 31, 2019filed Dec 20, 2019FY2018ended Oct 31, 2018filed Dec 17, 2018FY2017ended Oct 31, 2017filed Dec 14, 2017FY2016ended Oct 31, 2016filed Dec 12, 2016FY2015ended Oct 31, 2015filed Dec 14, 2015FY2014ended Oct 31, 2014filed Dec 15, 2014FY2013ended Oct 31, 2013filed Dec 20, 2013FY2012ended Oct 31, 2012filed Dec 20, 2012FY2011ended Oct 31, 2011filed Dec 16, 2011FY2010ended Oct 31, 2010filed Dec 17, 2010FY2009ended Oct 31, 2009filed Sep 8, 2010FY2008ended Oct 31, 2008filed Sep 8, 2010
Revenue7,0546,1275,3184,6164,2043,6853,3613,1212,725—————————
Cost of revenue1,6241,2451,031898862795753736654543519457454393340281274259
Gross profit5,4314,8824,2873,7183,3422,8912,6082,3852,0711,8801,7231,6011,5091,3631,1951,1001,0861,078
Research and development2,4792,0821,8501,5901,5051,2791,1371,085909857776719669582492449420395
Selling, general and administrative770568377314323285229263197166165155144157113115119104
Operating income9151,3561,2731,149735620520360348317266249246190213184208219
Other income (expense)92519535(45)7118253361215232911615250
Pretax income1,3931,5141,3051,103806638546364383330282272276201219199233219
Income tax561009013949(25)13(69)2476356132819(2)(38)6529
Net income1,3322,2631,230985758664532433137267226259248182221237168190
Diluted EPS ($)8.0414.517.926.294.814.273.452.820.881.731.431.641.581.211.471.561.151.29
Diluted shares (millions)166156155156157156154153155155158158157150150152146148

Balance sheet

Synopsys Inc balance sheet, annual
Millions of dollarsFY2025ended Oct 31, 2025filed Dec 22, 2025FY2024ended Oct 31, 2024filed Dec 19, 2024FY2023ended Oct 31, 2023filed Dec 12, 2023FY2022ended Oct 31, 2022filed Dec 12, 2022FY2021ended Oct 31, 2021filed Dec 13, 2021FY2020ended Oct 31, 2020filed Dec 15, 2020FY2019ended Oct 31, 2019filed Dec 20, 2019FY2018ended Oct 31, 2018filed Dec 17, 2018FY2017ended Oct 31, 2017filed Dec 14, 2017FY2016ended Oct 31, 2016filed Dec 12, 2016FY2015ended Oct 31, 2015filed Dec 14, 2015FY2014ended Oct 31, 2014filed Dec 15, 2014FY2013ended Oct 31, 2013filed Dec 20, 2013FY2012ended Oct 31, 2012filed Dec 20, 2012FY2011ended Oct 31, 2011filed Dec 16, 2011FY2010ended Oct 31, 2010filed Dec 17, 2010FY2009ended Oct 31, 2009filed Sep 8, 2010FY2008ended Oct 31, 2008filed Sep 8, 2010
Cash and equivalents2,8883,8971,4341,4181,4331,2367297231,0489778369861,022700855775702578
Short-term investments731541521481480——01411290——149163467—
Total current assets6,0126,4703,4313,0132,8082,5491,7391,5441,6831,7171,4691,5051,4481,1411,3381,2481,464—
Total assets48,22413,07410,3339,4188,7528,0306,4056,1465,3965,2405,0464,7754,3594,1483,3693,2872,939—
Total current liabilities3,7222,6502,9852,7742,4132,1401,7522,1021,6141,7151,5781,3871,2231,2531,010922815—
Long-term debt13,46216182125101120126134004575105————
Total liabilities19,8974,0504,1493,8593,4533,1182,3162,6612,1172,0451,9121,7191,5711,6041,2681,1861,095—
Stockholders’ equity28,3288,9916,1475,5165,2954,9074,0833,4793,2763,1953,1343,0562,7882,5022,1012,1001,844—
Shares outstanding (millions)191155152152153153151150149150151153154151144149——

Cash flow statement

Synopsys Inc cash flow statement, annual
Millions of dollarsFY2025ended Oct 31, 2025filed Dec 22, 2025FY2024ended Oct 31, 2024filed Dec 19, 2024FY2023ended Oct 31, 2023filed Dec 12, 2023FY2022ended Oct 31, 2022filed Dec 12, 2022FY2021ended Oct 31, 2021filed Dec 13, 2021FY2020ended Oct 31, 2020filed Dec 15, 2020FY2019ended Oct 31, 2019filed Dec 20, 2019FY2018ended Oct 31, 2018filed Dec 17, 2018FY2017ended Oct 31, 2017filed Dec 14, 2017FY2016ended Oct 31, 2016filed Dec 12, 2016FY2015ended Oct 31, 2015filed Dec 14, 2015FY2014ended Oct 31, 2014filed Dec 15, 2014FY2013ended Oct 31, 2013filed Dec 20, 2013FY2012ended Oct 31, 2012filed Dec 20, 2012FY2011ended Oct 31, 2011filed Dec 16, 2011FY2010ended Oct 31, 2010filed Dec 17, 2010FY2009ended Oct 31, 2009filed Sep 8, 2010FY2008ended Oct 31, 2008filed Sep 8, 2010
Operating cash flow1,5191,4071,7031,7391,493991801424632——551497486440341239331
Capital expenditures1691401901379415519899706787103655457393939
Free cash flow (CFO − capex)1,3491,2681,5141,6021,399837602325562——448431432383302200292
Depreciation and amortization66029524722820421020220918920721219318715712910110197
Share repurchases001,1611,10075324232940038040026012014540402185—220
Dividends paid——————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 2, 2024 to November 2, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$51M
9 sales by 4 insiders; officers and directors $51M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$62M
15 sales by 5 insiders; officers and directors $62M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Ghazi SassinePRESIDENT AND CEO, Directoroption exercise14,604$135.88$2M91,469Oct 16, 2026
Oct 15, 2026Ghazi SassinePRESIDENT AND CEO, Directoropen-market sale10b5-114,604$462.84$7M76,865Oct 16, 2026
Oct 6, 2026Lee JanetGC & Corporate Secretaryopen-market sale584$502.64$293K17,094Oct 7, 2026
Oct 6, 2026Lee JanetGC & Corporate Secretaryopen-market sale560$502.39$281K16,534Oct 7, 2026
Oct 6, 2026Kankanwadi SudhindraDeputy CFO & CAOoption exercise9,170$135.88$1M31,887Oct 6, 2026
Oct 6, 2026Kankanwadi SudhindraDeputy CFO & CAOopen-market sale9,170$500.00$5M22,717Oct 6, 2026
Oct 5, 2026Kankanwadi SudhindraDeputy CFO & CAOoption exercise3,000$135.88$408K25,717Oct 6, 2026
Oct 5, 2026Kankanwadi SudhindraDeputy CFO & CAOopen-market sale3,000$484.78$1M22,717Oct 6, 2026
Sep 15, 2026Ghazi SassinePRESIDENT AND CEO, Directoroption exercise14,604$135.88$2M91,469Sep 16, 2026
Sep 15, 2026Ghazi SassinePRESIDENT AND CEO, Directoropen-market sale10b5-114,604$374.88$5M76,865Sep 16, 2026
Sep 11, 2026Lee JanetGC & Corporate Secretaryoption exercise2,283$0.00—18,671Sep 14, 2026
Sep 11, 2026Lee JanetGC & Corporate Secretarytax withholding993$397.38$395K17,678Sep 14, 2026
Sep 1, 2026Lee JanetGC & Corporate Secretaryoption exercise699$0.00—16,692Sep 2, 2026
Sep 1, 2026Lee JanetGC & Corporate Secretarytax withholding304$414.82$126K16,388Sep 2, 2026
Sep 1, 2026DE Geus AartEXECUTIVE CHAIR, Directoroption exercise24,641$135.88$3M145,084Sep 2, 2026
Sep 1, 2026DE Geus AartEXECUTIVE CHAIR, Directoropen-market sale10b5-124,641$419.44$10M120,443Sep 2, 2026
Aug 31, 2026Ghazi SassinePRESIDENT AND CEO, Directorother27$360.96$10K76,865Sep 2, 2026
Aug 31, 2026Kankanwadi SudhindraDeputy CFO & CAOother27$360.96$10K22,717Sep 2, 2026
Aug 31, 2026Ellow MichaelChief Revenue Officerother27$360.96$10K2,612Sep 2, 2026
Aug 31, 2026DE Geus AartEXECUTIVE CHAIR, Directoroption exercise25,000$135.88$3M145,421Sep 2, 2026
Aug 31, 2026DE Geus AartEXECUTIVE CHAIR, Directoropen-market sale10b5-125,000$441.76$11M120,421Sep 2, 2026
Aug 31, 2026DE Geus AartEXECUTIVE CHAIR, Directorother22$360.96$8K120,443Sep 2, 2026
Aug 28, 2026DE Geus AartEXECUTIVE CHAIR, Directoroption exercise25,000$135.88$3M145,421Aug 31, 2026
Aug 28, 2026DE Geus AartEXECUTIVE CHAIR, Directoropen-market sale10b5-125,000$445.55$11M120,421Aug 31, 2026
Aug 16, 2026Lee JanetGC & Corporate Secretaryoption exercise729$0.00—16,311Aug 17, 2026

Full insider history for Synopsys Inc, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

3 of the tracked managers held SNPS in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded SNPS by quarter.

FundManagerQuarterValueSharesWeightMove
Altimeter CapitalBrad GerstnerQ2 2026$63M140,3430.64%new
Elliott Investment ManagementPaul SingerQ2 2026$101M227,5000.45%new
Baron Capital GroupRon BaronQ2 2026$439K9850.00%trimmed −78.0%

Sources

Fiscal year ends in month 10; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
SYNOPSYS INC, CIK 883241 on EDGAR
Extract generated
August 27, 2026
Withheld
3 line-years whose four quarters do not sum to the filed year: cost of revenue FY2023, gross profit FY2023, revenue FY2023
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/SNPS.json